The bronchoscopy market is expected to witness huge demand in coming years. To address the therapeutic needs of these patients, organizations like the AABIP (American Association for Bronchology and Interventional Pulmonology) have also issued recommendations to ensure the safe and effective use of bronchoscopy. In addition, COPD (chronic obstructive pulmonary disease) is emerging as the third leading cause of mortality worldwide, causing over 3.23 million deaths in 2019, thereby generating opportunities for bronchoscopy market growth over the years.

With the increasing technological innovation, healthcare companies are consistently advancing therapeutic bronchoscopy procedures with the use of robot-assisted technology.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/5249

The bronchoscopy procedure has long been a popular method used to diagnose and treat lung diseases. In wake of the coronavirus pandemic, the procedure is gaining massive popularity, as it can help improve mechanical ventilation in critically ill COVID-19 patients through the removal of intrabronchial clots and mucus plugs, as well as the resolution of atelectasis.

Listed below are 4 such initiatives powering the bronchoscopy market expansion:

Olympus’ FDA-cleared BF-UC190F EBUS bronchoscope for lung cancer

Over the years, regulatory bodies have been giving approvals for various minimally invasive devices for use in the treatment of lung cancer. For example, in May 2021, Olympus unveiled an FDA 510(k)-cleared BF-UC190F EBUS (endobronchial ultrasound) bronchoscope, a new addition to its EBUS portfolio for minimally invasive diagnosis and staging of lung cancer via needle biopsy.

As per the American College of Chest Physicians, correct staging of patients with lung cancer is critical, as the prognosis and treatment options differ significantly by stage. In line with this, the medical association has recommended EBUS-TBNA (endobronchial ultrasound-guided transbronchial needle aspiration) as the optimal first test than surgery for mediastinal staging, thus proliferating the use of bronchoscopy for lung cancer treatments.

FDA approval of Boston Scientific’s Single-Use Bronchoscope for bedside procedures

To increase patient safety and enhance operational efficiencies in the hospital setting, several physicians are making a transition to single-use bronchoscopes. This device can eliminate the risks of infections associated with the use of reusable systems and time-intensive scope reprocessing.

To cite an instance, in August 2021, the U.S. FDA granted 510(k) clearance to the EXALT Model B Single-Use Bronchoscope of Boston Scientific for use in bedside procedures in the ICUs (intensive care units) and ORs (operating rooms). The device was designed to optimize the suction and imaging performance of single-use bronchoscopes. Developments of devices with infection control benefits such as these could consequently assert a positive influence on bronchoscopy market development over the forthcoming years.

PENTAX Medical’s single-use bronchoscope for pulmonary care

Endoscopic imaging solutions providers are committed to addressing the hygiene challenges of medical devices through continuous product innovation and optimization. Citing an instance, in May 2021, PENTAX Medical Europe gained a CE mark for the PENTAX Medical ONE Pulmo, its single-use bronchoscope. This innovative product was designed to provide quality care with no compromise on pulmonary care.

Request for Customization @ https://www.gminsights.com/roc/5249

Notably, the PENTAX Medical ONE Pulmo can offer sterility with HD visualization, thereby broadening the clinical applications of bronchoscopes beyond the standard disposable scope and influencing the overall bronchoscopy market outlook. In addition, its large working channel can provide up to 50% more suction power to ensure quick and efficient patient care.

Manipal Hospitals’ interventional pulmonology unit equipped with rigid bronchoscopy

In developing nations, healthcare facilities are focusing on deploying state-of-the-art respiratory critical care units, which adopt innovative technology for interventional pulmonology, to effectively treat lung diseases.

For example, in April 2022, Manipal Hospitals in India launched its interventional pulmonology unit with advanced equipment to diagnose and treat lung diseases. Equipment such as EBUS (endobronchial ultrasound) as well as rigid bronchoscopy, thoracoscopy, and airway stenting were made available at this unit, which helped augment the popularity of the bronchoscopy procedure in the region.

About Global Market Insights:

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Contact Us:

Aashit Tiwari

Corporate Sales, USA

Global Market Insights, Inc.

Phone: 1-302-846-7766

Toll Free: 1-888-689-0688

Email: sales@gminsights.com

Web: https://www.gminsights.com